Tools · Private company · San Mateo, CA, US
Bioamp Diagnostics, Inc.
Track this companyFree. Adds Bioamp Diagnostics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Evolving the standard of care for carbapenem resistant infections, through the development of a phenotypic assay capable of DETECTing and classifying carbapenemasesFiscal year 2025 · $79.3KNIH RePORTER 5R43AI181482-02 · fetched Nov 12, 2026
- Evolving the standard of care for carbapenem resistant infections, through the development of a phenotypic assay capable of DETECTing and classifying carbapenemasesFiscal year 2024 · $243.8KNIH RePORTER 1R43AI181482-01 · fetched Nov 12, 2026